Childhood stroke as the presentation of Takayasu's arteritis: Diagnostic delay can cause catastrophic complications

Journal of Rheumatology

Volumn 35, Issue 6, 2008, Pages 1228-1230

  Brunner, Juergen ^a,b   Armstrong, Derek ^c   Feldman, Brian M ^a   Schneider, Rayfel ^c   Benseler, Suse ^c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c Hospital for Sick Children

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOPHOSPHAMIDE; GABAPENTIN; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; SMALL HEAT SHOCK PROTEIN;

AORTA ARCH SYNDROME; BLOOD PRESSURE MEASUREMENT; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCHOOL CHILD; STROKE;

ANGIOGRAPHY; CHILD; FEMALE; HUMANS; STROKE; TAKAYASU ARTERITIS; TIME FACTORS;

EID: 44949103344     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (17)

1. Dedeoglu F, Sundel RP. Vasculitis in children. Pediatr Clin North Am 2005;52:547-75.
2. Kerr GS, Hallahan CW, Giordano J, et al. Takayasu arteritis. Ann Intern Med 1994;120:919-29.
3. Johnston SL, Lock RJ, Gompels MM. Takayasu arteritis: a review. J Clin Pathol 2002;55:481-6.
4. Arend WP, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 1990;33:1129-34.
5. Ozen S, Ruperte N, Dillon MJ, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 2006;65:936-41.
6. Gravanis MB. Giant cell arteritis and Takayasu aortitis: morphologic, pathogenetic and etiologic factors. Int J Cardiol 2000;75 Suppl 1:21-33, discussion 35-6.
7. Hahn D, Thomson PD, Kala U, Beale PG, Levin SE. A review of Takayasu's arteritis in children in Gauteng, South Africa. Pediatr Nephrol 1998;12:668-75.
8. Morales E, Pineda C, Martinez-Lavin M. Takayasu's arteritis in children. J Rheumatol 1991;18:1081-4.
9. Ozen S, Bakkaloglu A, Dusunsel R, et al. Childhood vasculitides in Turkey: a nationwide survey. Clin Rheumatol 2007;26:196-200.
10. Hong CY, Yun YS, Choi JY, et al. Takayasu arteritis in Korean children: clinical report of seventy cases. Heart Vessels Suppl 1992;7:91-6.
11. Jain S, Kumari S, Ganguly NK, Sharma BK. Current status of Takayasu arteritis in India. Int J Cardiol 1996;54 Suppl:111-6.
12. Muranjan MN, Bavdekar SB, More V, Deshmukh H, Tripathi M, Vaswani R. Study of Takayasu's arteritis in children: clinical profile and management. J Postgrad Med 2000;46:3-8.
13. Benseler SM, Silverman E, Aviv RI, et al. Primary central nervous system vasculitis in children. Arthritis Rheum 2006;54:1291-7.
14. Hall S, Barr W, Lie JT, Stanson AW, Kazmier FJ, Hunder GG. Takayasu arteritis. A study of 32 North American patients. Medicine (Baltimore) 1985;64:89-99.
15. Hoffman GS. Takayasu arteritis: lessons from the American National Institutes of Health experience. Int J Cardiol 1996;54Suppl:99-102.
16. Sikaroodi H, Motamedi M, Kahnooji H, Gholamrezanezhad A, Yousefi N. Stroke as the first manifestation of Takayasu arteritis. Acta Neurol Belg 2007;107:18-21.
17. Ozen S, Duzova A, Bakkaloglu A, et al. Takayasu arteritis in children: preliminary experience with cyclophosphamide induction and corticosteroids followed by methotrexate. J Pediatr 2007;150:72-6.